[ad_1]
SCREENSHOT OF LA7
“The setback of the Oxford AstraZeneca vaccine is physiological and normal, it is not a stop but an evaluation phase, a vaccine has never been developed in a year, it takes more than three years.” Thus, on 24 Mattino on Radio24 Andrea Crisanti, professor of microbiology at the University of Padua, comments on the temporary suspension of the trials, worldwide, of the anti-Covid vaccine developed by the University of Oxford to be produced by the Anglo pharmaceutical group . The Swedish AstraZeneca, among the most promising of the more than 100 studied in the world. The temporary stoppage was decided after one of the participants reported “a possible serious adverse reaction.”
“The process is long and complex, the development of a vaccine takes about 5 years. The efforts are justified because it is a measure that is more convenient from the point of view of cost and effectiveness, but it takes time ”.
For Matteo Bassetti, infectious diseases specialist at the San Martino Polyclinic Hospital in Genoa, “I regret the cessation of experimentation, but it is a sign that companies are working seriously, transparently and verifying the data. This is the strongest argument we can have against vaccine naysayers and non-vaxes who attacked that it would be marketed without evidence. Here, this is the best answer that could be given to them ”, emphasizes the specialist in infectious diseases. “There was a problem and the company was not ashamed to say stoppiano and let’s see what happened. We hope that they will resume soon but it is the demonstration that the investigation is regulated and transparent ”, concluded Bassetti.
“As usual, if we want to see the glass half empty, then there is this aspect”, the fact that there are abnormal reactions to the trials of the AstraZeneca-Oxford vaccine, which is what Italy is also working on, and that there are delays ; But if we want to see the glass half full, then it is confirmation that things are done very well in Italy, that when it comes to having a vaccine it will be safe because it will have passed all the tests that need to be passed ”. This was stated by Alberto Villani, director of Infectious Diseases at the Bambino Gesù hospital in Rome, invited to Agorà in Rai 3. “We also take into account that there are a few dozen vaccines under test in the world – he added – and we must take into account what work “. On the waiting times for a vaccine that is usable by the population, he observed: “Making predictions is always very difficult. Usually 10-15 are studied together. Here – he stressed – hundreds of them are studied so the probabilities are statistically greater of being able to have a safe and usable vaccine in much shorter times ”, times that“ are generally years ”, he concluded.
[ad_2]
